Novel founder intronic variant in SLC39A14 in two families causing Manganism and potential treatment strategies

Lance H. Rodan, Marissa Hauptman, Alissa M. D'Gama, Anita E. Qualls, Siqi Cao, Karin Tuschl, Fatma Al-Jasmi, Jozef Hertecant, Susan Hayflick, Marianne Wessling-Resnick, Edward T. Yang, Gerard T. Berry, Andrea Gropman, Alan D. Woolf, Pankaj B. Agrawal

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Congenital disorders of manganese metabolism are rare occurrences in children, and medical management of these disorders is complex and challenging. Homozygous exonic mutations in the manganese transporter SLC39A14 have recently been associated with a pediatric-onset neurodegenerative disorder characterized by brain manganese accumulation and clinical signs of manganese neurotoxicity, including parkinsonism-dystonia. We performed whole exome sequencing on DNA samples from two unrelated female children from the United Arab Emirates with progressive movement disorder and brain mineralization, identified a novel homozygous intronic mutation in SLC39A14 in both children, and demonstrated that the mutation leads to aberrant splicing. Both children had consistently elevated serum manganese levels and were diagnosed with SLC39A14-associated manganism. Over a four-year period, we utilized a multidisciplinary management approach for Patient 1 combining decreased manganese dietary intake and chelation with symptomatic management of dystonia. Our treatment strategy appeared to slow disease progression, but did not lead to a cure or reversal of already established deficits. Clinicians should consider testing for noncoding mutations in the diagnosis of congenital disorders of manganese metabolism and utilizing multidisciplinary approaches in the management of these disorders.

Original languageEnglish (US)
JournalMolecular Genetics and Metabolism
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Manganese
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Mutation
Dystonia
Metabolism
Therapeutics
Brain
United Arab Emirates
Exome
Pediatrics
Movement Disorders
Parkinsonian Disorders
Chelation
DNA Sequence Analysis
Neurodegenerative Diseases
Disease Progression
DNA
Testing
Serum

Keywords

  • Congenital manganism
  • Manganese toxicity
  • SLC39A14

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology

Cite this

Novel founder intronic variant in SLC39A14 in two families causing Manganism and potential treatment strategies. / Rodan, Lance H.; Hauptman, Marissa; D'Gama, Alissa M.; Qualls, Anita E.; Cao, Siqi; Tuschl, Karin; Al-Jasmi, Fatma; Hertecant, Jozef; Hayflick, Susan; Wessling-Resnick, Marianne; Yang, Edward T.; Berry, Gerard T.; Gropman, Andrea; Woolf, Alan D.; Agrawal, Pankaj B.

In: Molecular Genetics and Metabolism, 01.01.2018.

Research output: Contribution to journalArticle

Rodan, LH, Hauptman, M, D'Gama, AM, Qualls, AE, Cao, S, Tuschl, K, Al-Jasmi, F, Hertecant, J, Hayflick, S, Wessling-Resnick, M, Yang, ET, Berry, GT, Gropman, A, Woolf, AD & Agrawal, PB 2018, 'Novel founder intronic variant in SLC39A14 in two families causing Manganism and potential treatment strategies', Molecular Genetics and Metabolism. https://doi.org/10.1016/j.ymgme.2018.04.002
Rodan, Lance H. ; Hauptman, Marissa ; D'Gama, Alissa M. ; Qualls, Anita E. ; Cao, Siqi ; Tuschl, Karin ; Al-Jasmi, Fatma ; Hertecant, Jozef ; Hayflick, Susan ; Wessling-Resnick, Marianne ; Yang, Edward T. ; Berry, Gerard T. ; Gropman, Andrea ; Woolf, Alan D. ; Agrawal, Pankaj B. / Novel founder intronic variant in SLC39A14 in two families causing Manganism and potential treatment strategies. In: Molecular Genetics and Metabolism. 2018.
@article{4f8ddbc669954a8bb2c92a4da1d14abc,
title = "Novel founder intronic variant in SLC39A14 in two families causing Manganism and potential treatment strategies",
abstract = "Congenital disorders of manganese metabolism are rare occurrences in children, and medical management of these disorders is complex and challenging. Homozygous exonic mutations in the manganese transporter SLC39A14 have recently been associated with a pediatric-onset neurodegenerative disorder characterized by brain manganese accumulation and clinical signs of manganese neurotoxicity, including parkinsonism-dystonia. We performed whole exome sequencing on DNA samples from two unrelated female children from the United Arab Emirates with progressive movement disorder and brain mineralization, identified a novel homozygous intronic mutation in SLC39A14 in both children, and demonstrated that the mutation leads to aberrant splicing. Both children had consistently elevated serum manganese levels and were diagnosed with SLC39A14-associated manganism. Over a four-year period, we utilized a multidisciplinary management approach for Patient 1 combining decreased manganese dietary intake and chelation with symptomatic management of dystonia. Our treatment strategy appeared to slow disease progression, but did not lead to a cure or reversal of already established deficits. Clinicians should consider testing for noncoding mutations in the diagnosis of congenital disorders of manganese metabolism and utilizing multidisciplinary approaches in the management of these disorders.",
keywords = "Congenital manganism, Manganese toxicity, SLC39A14",
author = "Rodan, {Lance H.} and Marissa Hauptman and D'Gama, {Alissa M.} and Qualls, {Anita E.} and Siqi Cao and Karin Tuschl and Fatma Al-Jasmi and Jozef Hertecant and Susan Hayflick and Marianne Wessling-Resnick and Yang, {Edward T.} and Berry, {Gerard T.} and Andrea Gropman and Woolf, {Alan D.} and Agrawal, {Pankaj B.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.ymgme.2018.04.002",
language = "English (US)",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Novel founder intronic variant in SLC39A14 in two families causing Manganism and potential treatment strategies

AU - Rodan, Lance H.

AU - Hauptman, Marissa

AU - D'Gama, Alissa M.

AU - Qualls, Anita E.

AU - Cao, Siqi

AU - Tuschl, Karin

AU - Al-Jasmi, Fatma

AU - Hertecant, Jozef

AU - Hayflick, Susan

AU - Wessling-Resnick, Marianne

AU - Yang, Edward T.

AU - Berry, Gerard T.

AU - Gropman, Andrea

AU - Woolf, Alan D.

AU - Agrawal, Pankaj B.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Congenital disorders of manganese metabolism are rare occurrences in children, and medical management of these disorders is complex and challenging. Homozygous exonic mutations in the manganese transporter SLC39A14 have recently been associated with a pediatric-onset neurodegenerative disorder characterized by brain manganese accumulation and clinical signs of manganese neurotoxicity, including parkinsonism-dystonia. We performed whole exome sequencing on DNA samples from two unrelated female children from the United Arab Emirates with progressive movement disorder and brain mineralization, identified a novel homozygous intronic mutation in SLC39A14 in both children, and demonstrated that the mutation leads to aberrant splicing. Both children had consistently elevated serum manganese levels and were diagnosed with SLC39A14-associated manganism. Over a four-year period, we utilized a multidisciplinary management approach for Patient 1 combining decreased manganese dietary intake and chelation with symptomatic management of dystonia. Our treatment strategy appeared to slow disease progression, but did not lead to a cure or reversal of already established deficits. Clinicians should consider testing for noncoding mutations in the diagnosis of congenital disorders of manganese metabolism and utilizing multidisciplinary approaches in the management of these disorders.

AB - Congenital disorders of manganese metabolism are rare occurrences in children, and medical management of these disorders is complex and challenging. Homozygous exonic mutations in the manganese transporter SLC39A14 have recently been associated with a pediatric-onset neurodegenerative disorder characterized by brain manganese accumulation and clinical signs of manganese neurotoxicity, including parkinsonism-dystonia. We performed whole exome sequencing on DNA samples from two unrelated female children from the United Arab Emirates with progressive movement disorder and brain mineralization, identified a novel homozygous intronic mutation in SLC39A14 in both children, and demonstrated that the mutation leads to aberrant splicing. Both children had consistently elevated serum manganese levels and were diagnosed with SLC39A14-associated manganism. Over a four-year period, we utilized a multidisciplinary management approach for Patient 1 combining decreased manganese dietary intake and chelation with symptomatic management of dystonia. Our treatment strategy appeared to slow disease progression, but did not lead to a cure or reversal of already established deficits. Clinicians should consider testing for noncoding mutations in the diagnosis of congenital disorders of manganese metabolism and utilizing multidisciplinary approaches in the management of these disorders.

KW - Congenital manganism

KW - Manganese toxicity

KW - SLC39A14

UR - http://www.scopus.com/inward/record.url?scp=85045920601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045920601&partnerID=8YFLogxK

U2 - 10.1016/j.ymgme.2018.04.002

DO - 10.1016/j.ymgme.2018.04.002

M3 - Article

C2 - 29685658

AN - SCOPUS:85045920601

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

ER -